Antioxidant proteins can be potential targets in ameliorating ferroptosis in diabetic cardiomyopathy: a literature review

Abstract Diabetic cardiomyopathy (DCM) is one of the cardiovascular complications of diabetes mellitus, which is different from myocardial damage caused by coronary ischemia, hypertension, and valvular disease. DCM lacks distinct clinical manifestations in its early stages, and current therapeutic a...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuting Lin, Shu Yang, Jinjian Guo
Format: Article
Language:English
Published: BMC 2025-06-01
Series:Diabetology & Metabolic Syndrome
Subjects:
Online Access:https://doi.org/10.1186/s13098-025-01773-x
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849725109741289472
author Yuting Lin
Shu Yang
Jinjian Guo
author_facet Yuting Lin
Shu Yang
Jinjian Guo
author_sort Yuting Lin
collection DOAJ
description Abstract Diabetic cardiomyopathy (DCM) is one of the cardiovascular complications of diabetes mellitus, which is different from myocardial damage caused by coronary ischemia, hypertension, and valvular disease. DCM lacks distinct clinical manifestations in its early stages, and current therapeutic approaches primarily focus on symptomatic management. Emerging evidence indicates that even with optimized glycemic regulation, the pathophysiological progression of DCM remains unmitigated. Exploring the pathogenic mechanism of DCM is the focus and hotspot of current research. Ferroptosis, an iron-dependent form of regulatory cell death, is crucial in DCM myocardial damage. Dysfunctional antioxidant defense system, increased oxidative stress, and elevated reactive oxygen species are the key mechanisms of ferroptosis in DCM. Thus, this review innovatively takes antioxidant proteins as the entry point, and for the first time systematically summarizes the molecular mechanism of antioxidant proteins to improve DCM by regulating the ferroptosis pathway, and summarizes the therapeutic strategy of medications to enhance ferroptosis in DCM by targeting the expression of antioxidant proteins, to explore the potential targets to improve ferroptosis in DCM, to provide a new perspective for the study of delaying the progression of DCM.
format Article
id doaj-art-2f442a94db7e456c973a6067ce3ad2f3
institution DOAJ
issn 1758-5996
language English
publishDate 2025-06-01
publisher BMC
record_format Article
series Diabetology & Metabolic Syndrome
spelling doaj-art-2f442a94db7e456c973a6067ce3ad2f32025-08-20T03:10:34ZengBMCDiabetology & Metabolic Syndrome1758-59962025-06-0117111310.1186/s13098-025-01773-xAntioxidant proteins can be potential targets in ameliorating ferroptosis in diabetic cardiomyopathy: a literature reviewYuting Lin0Shu Yang1Jinjian Guo2Department of Cardiology, The Second Affiliated Hospital of Fujian University of Traditional Chinese MedicineThe Second Affiliated Hospital of Fujian Medical UniversityDepartment of Cardiology, The Second Affiliated Hospital of Fujian University of Traditional Chinese MedicineAbstract Diabetic cardiomyopathy (DCM) is one of the cardiovascular complications of diabetes mellitus, which is different from myocardial damage caused by coronary ischemia, hypertension, and valvular disease. DCM lacks distinct clinical manifestations in its early stages, and current therapeutic approaches primarily focus on symptomatic management. Emerging evidence indicates that even with optimized glycemic regulation, the pathophysiological progression of DCM remains unmitigated. Exploring the pathogenic mechanism of DCM is the focus and hotspot of current research. Ferroptosis, an iron-dependent form of regulatory cell death, is crucial in DCM myocardial damage. Dysfunctional antioxidant defense system, increased oxidative stress, and elevated reactive oxygen species are the key mechanisms of ferroptosis in DCM. Thus, this review innovatively takes antioxidant proteins as the entry point, and for the first time systematically summarizes the molecular mechanism of antioxidant proteins to improve DCM by regulating the ferroptosis pathway, and summarizes the therapeutic strategy of medications to enhance ferroptosis in DCM by targeting the expression of antioxidant proteins, to explore the potential targets to improve ferroptosis in DCM, to provide a new perspective for the study of delaying the progression of DCM.https://doi.org/10.1186/s13098-025-01773-xDiabetic cardiomyopathyFerroptosisOxidative stressAntioxidant proteinsTherapy
spellingShingle Yuting Lin
Shu Yang
Jinjian Guo
Antioxidant proteins can be potential targets in ameliorating ferroptosis in diabetic cardiomyopathy: a literature review
Diabetology & Metabolic Syndrome
Diabetic cardiomyopathy
Ferroptosis
Oxidative stress
Antioxidant proteins
Therapy
title Antioxidant proteins can be potential targets in ameliorating ferroptosis in diabetic cardiomyopathy: a literature review
title_full Antioxidant proteins can be potential targets in ameliorating ferroptosis in diabetic cardiomyopathy: a literature review
title_fullStr Antioxidant proteins can be potential targets in ameliorating ferroptosis in diabetic cardiomyopathy: a literature review
title_full_unstemmed Antioxidant proteins can be potential targets in ameliorating ferroptosis in diabetic cardiomyopathy: a literature review
title_short Antioxidant proteins can be potential targets in ameliorating ferroptosis in diabetic cardiomyopathy: a literature review
title_sort antioxidant proteins can be potential targets in ameliorating ferroptosis in diabetic cardiomyopathy a literature review
topic Diabetic cardiomyopathy
Ferroptosis
Oxidative stress
Antioxidant proteins
Therapy
url https://doi.org/10.1186/s13098-025-01773-x
work_keys_str_mv AT yutinglin antioxidantproteinscanbepotentialtargetsinamelioratingferroptosisindiabeticcardiomyopathyaliteraturereview
AT shuyang antioxidantproteinscanbepotentialtargetsinamelioratingferroptosisindiabeticcardiomyopathyaliteraturereview
AT jinjianguo antioxidantproteinscanbepotentialtargetsinamelioratingferroptosisindiabeticcardiomyopathyaliteraturereview